Multiplex end-tagging amplification of nucleic acids

US11530436B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11530436-B2
Application numberUS-201816615872-A
CountryUS
Kind codeB2
Filing dateMay 23, 2018
Priority dateMay 23, 2017
Publication dateDec 20, 2022
Grant dateDec 20, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure provides a method for assembly of genomic DNA using multiplex end-tagging amplification of genomic fragments.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of DNA amplification comprising contacting genomic DNA with a library of transposomes with each transposome of the library having two transposases and two transposon DNA, wherein each transposon DNA includes a transposase binding site and a primer binding site sequence, wherein the primer binding site sequence is different from the primer binding site of other members of the transposome library, and wherein each transposome within the library of transposomes includes two different primer binding site sequences, wherein the library of transposomes bind to target locations along the genomic DNA and the transposase cleaves the genomic DNA into a plurality of double stranded genomic DNA fragments representing a genomic DNA fragment library, with each double stranded genomic DNA fragment includes a unique and/or different primer binding site sequence on each end of the genomic DNA fragment, filling a gap between the transposon DNA and the genomic DNA fragment to form a library of double stranded genomic DNA fragment extension products having unique and/or different primer binding site sequences at each end, and amplifying the double stranded genomic DNA fragment extension products to produce amplicons. 2. The method of claim 1 further including sequencing the amplicons. 3. The method of claim 1 wherein the genomic DNA is whole genomic DNA obtained from a single cell. 4. The method of claim 1 wherein the transposase is Tn5 transposase, Mu transposase, Tn7 transposase or IS5 transposase. 5. The method of claim 1 wherein the transposon DNA includes a double-stranded 19 bp Tnp binding site and an overhang, wherein the overhang includes a unique and/or different primer binding site sequence at the 5′ end of the overhang. 6. The method of claim 1 wherein bound transposases are removed from the double stranded fragments before gap filling and extending of the double stranded genomic DNA fragments. 7. The method of claim 1 wherein the genomic DNA is from a prenatal cell. 8. The method of claim 1 wherein the genomic DNA is from a cancer cell. 9. The method of claim 1 wherein the genomic DNA is from a circulating tumor cell. 10. The method of claim 1 wherein the genomic DNA is from a single prenatal cell. 11. The method of claim 1 wherein the genomic DNA is from a single cancer cell. 12. The method of claim 1 wherein the genomic DNA is from a single circulating tumor cell. 13. The method of claim 1 where the genomic DNA is the product of chromatin conformation capture from a single cell or a small sample. 14. The method of claim 1 where the genomic DNA is the native or fixed chromatin from a single cell or minute amount of samples. 15. The method of claim 1 wherein the unique and different primer binding site sequence is a specific PCR primer binding site. 16. The method of claim 1 wherein the library of transposomes includes 1 to 100 unique and different primer binding site sequences. 17. The method of claim 1 wherein the library of transposomes includes 1 to 10 unique and different primer binding site sequences. 18. The method of claim 1 wherein the library of transposomes includes 5 to 50 unique and different primer binding site sequences. 19. The method of claim 1 wherein the library of transposomes includes 30 to 100 unique and different primer binding site sequences. 20. The method of claim 1 wherein the library of transposomes includes 15 to 25 unique and different primer binding site sequences. 21. The method of claim 1 wherein the library of transposomes includes 100 to 1,000 unique and different primer binding site sequences. 22. The method of claim 1 wherein the library of transposomes includes 1,000 to 10,000 unique and different primer binding site sequences. 23. The method of claim 1 wherein the library of transposomes includes 10,000 to 100,000 unique and different primer binding site sequences. 24. The method of claim 1 wherein the different primer binding site sequences are orthogonal.

Assignees

Inventors

Classifications

  • Nucleic acid amplification reactions · CPC title

  • C12Q1/6806Primary

    Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title

  • Recombinase · CPC title

  • Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors · CPC title

  • incorporating/generating a new priming site · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11530436B2 cover?
The present disclosure provides a method for assembly of genomic DNA using multiplex end-tagging amplification of genomic fragments.
Who is the assignee on this patent?
Harvard College
What technology area does this patent fall under?
Primary CPC classification C12Q1/6806. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).